London: AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States, starting June, following a similar move ...
New Delhi: England cricketers have resorted to a sporadic use of inhalers to deal with high-pollution levels in major Indian cities over the course of their dismal World Cup ...